Home › Funds › SEIZERT CAPITAL PARTNERS, LLC › CVS
SEIZERT CAPITAL PARTNERS, LLC position in CVS
CVS HEALTH CORP · Consumer Staples
SEIZERT CAPITAL PARTNERS, LLC reported holding 100,154 shares of CVS (CVS HEALTH CORP) in its Q3 2026 13F filing — a position valued at US$8.6M, representing 0.37% of its reported portfolio and ranking #50 among its reported holdings. SEIZERT CAPITAL PARTNERS, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SEIZERT CAPITAL PARTNERS, LLC's CVS position evolved
SEIZERT CAPITAL PARTNERS, LLC first disclosed a stake in CVS in Q3 2023 at 449,153 shares (US$31.4M). The position peaked in Q1 2025 at 584,141 shares, worth US$39.6M. Across 13 filings, SEIZERT CAPITAL PARTNERS, LLC increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 100,154 shares valued at US$8.6M — a reduction of -47,135 shares quarter over quarter.. Notable position changes include a 74% trim in Q2 2025 (shares rose 10% over the following quarter), a 32% trim in Q3 2026 (shares rose 4% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 449.15K | $31.36M | New |
| Q4 2023 | 455.57K | $35.97M | Add |
| Q1 2024 | 463.35K | $36.96M | Add |
| Q2 2024 | 448.01K | $26.46M | Reduce |
| Q3 2024 | 463.82K | $29.16M | Add |
| Q4 2024 | 569.53K | $25.57M | Add |
| Q1 2025 | 584.14K | $39.58M | Add |
| Q2 2025 | 154.16K | $10.63M | Reduce |
| Q3 2025 | 150.79K | $11.37M | Reduce |
| Q4 2025 | 152.19K | $12.08M | Add |
| Q1 2026 | 159.98K | $11.49M | Add |
| Q2 2026 | 147.29K | $15.24M | Reduce |
| Q3 2026 | 100.15K | $8.58M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CVS and 13F data
CVS (CVS HEALTH CORP) is a Consumer Staples company. 31 other funds we track also report a position in CVS — the largest reported positions include Capital World Investors (US$7.75B), Capital World Investors (US$6.35B), Dodge & Cox (US$5.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CVS
- Capital World Investors 74.95M sh · $7.75B · Q2 2026
- Capital World Investors 74.04M sh · $6.35B · Q3 2026
- Dodge & Cox 50.01M sh · $5.17B · Q2 2026
- DODGE & COX 50.01M sh · $5.17B · Q2 2026
- Wellington Management Group 33.80M sh · $3.50B · Q2 2026
- WELLINGTON MANAGEMENT GROUP LLP 33.80M sh · $3.50B · Q2 2026
- DAVIS SELECTED ADVISERS 11.90M sh · $1.02B · Q3 2026
- Pzena Investment Management 10.30M sh · $882.34M · Q3 2026
More on SEIZERT CAPITAL PARTNERS, LLC
FAQ
How long has SEIZERT CAPITAL PARTNERS, LLC held CVS?
SEIZERT CAPITAL PARTNERS, LLC has disclosed CVS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SEIZERT CAPITAL PARTNERS, LLC's current position in CVS?
As of Q3 2026, SEIZERT CAPITAL PARTNERS, LLC holds 100.15K shares of CVS (CVS HEALTH CORP), valued at $8.58M, representing 0.37% of its reported portfolio and ranking #50.
Has SEIZERT CAPITAL PARTNERS, LLC been buying or selling CVS?
In the latest 13F filing (Q3 2026), SEIZERT CAPITAL PARTNERS, LLC reduced its position in CVS. The position peaked in Q1 2025 at 584.14K shares.
Which other funds hold CVS?
Other major institutional holders of CVS include Capital World Investors, Capital World Investors, Dodge & Cox, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.